Loading clinical trials...
Loading clinical trials...
Open-label study will titrate doses of intravenous atorvastatin and monitor respective LDL-C levels in hypercholesterolemic patients previously controlled on oral atorvastatin.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Cumberland Pharmaceuticals
NCT07473960 · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT06568601 · Hypercholesterolemia
NCT00353782 · Hypercholesterolemia, Atherosclerosis
NCT07037771 · Homozygous Familial Hypercholesterolemia
NCT07489209 · Homozygous Familial Hypercholesterolemia (HoFH)
Frontage Clinical Services
Secaucus, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions